Theravance Biopharma files material event with buried cost-sharing disclosures

FilingFirehose Daily · · 10 filings flagged · archive · RSS

Monday's SEC filings (241 8-Ks, 18 424B5s, 2 S-3s) surface three 8-Ks with nested structural complexity.

Top 3

  • Theravance Biopharma, Inc. — 8-K filed 2026-06-29; item 1.01 (Material Agreement) nests item 2.01 (Completion of Acquisition), item 8.01 (Other Events) nests item 1.01; score 125.
  • Volato Group, Inc. — 8-K filed 2026-06-29; item 1.01 (Material Agreement) with item 5.02 (Costs Associated) nesting both 1.01 and 3.01 (Material Modification); score 125.
  • FibroBiologics, Inc. — 8-K filed 2026-06-29; item 1.01 (Material Agreement) with item 3.02 (Unregistered Sales) nesting 1.01; score 100.

Paid subscribers see 7 more flagged filings + sector signals — upgrade for $9/mo

FilingFirehose Daily · 2026-06-30

Paid subscribers see 7 more flagged filings + cross-sector signal

Upgrade for $9/mo →

Free tier: top 3 filings every morning. One-click unsubscribe. No spam.